Hypertension impacts 1 billion people worldwide leading to catastrophic cardiovascular complications. Recent studies indicate that activated T lymphocytes make a key contribution to hypertension in part by stimulating sodium retention in the kidney. T lymphocytes undergo activation when the T cell receptor (TCR) binds a cognate antigen on the surface of an antigen presenting cell (APC). Our preliminary studies indicate that dendritic cells, the most potent APC lineage, infiltrate the kidney and activate T cells during the course of hypertension. After collecting and processing antigens, dendritic cells encounter and activate T cells in the lymph nodes draining the kidney with consequent downregulation of CD62L and upregulation of CD44 on these T cells. Expression of CCR7 on the T cell allows its entry into the lymph node for this critical dendritic cell encounter, and we find that mice deficiet of CCR7 (CCR7 KO) have a blunted chronic hypertensive response. We therefore hypothesize that dendritic cells potentiate blood pressure elevation by stimulating CCR7+ T lymphocytes to enhance sodium reabsorption in the kidney. To test this possibility we will induce hypertension in mice in which dendritic cells are conditionally ablated (DC DTR), genetically deficient (DC KO), or spontaneously activated (DC ACT). Our experiments will use two hypertension models that depend on T cell-driven sodium retention, the deoxycorticosterone acetate (DOCA)-salt and low dose chronic angiotensin (Ang) II infusion models. The DOCA-salt model mimicks hypertension in human patients with elevated aldosterone activity whereas the Ang II infusion model is relevant to the large numbers of human patients that respond to inhibition of the renin angiotensin system. Our preliminary data using radiotelemetry blood pressure measurements reveal that DC KO mice and DC ACT mice have blunted and augmented hypertensive responses, respectively, to low dose (300ng/kg/min) Ang II without measurable renal damage. To monitor specific TCR activation in the DC KO mice in vivo during hypertension, we have crossed the DC KOs with a GFP reporter strain in which T cells fluoresce green following TCR engagement by the APC. To determine whether the augmented hypertension seen in the DC ACT mice depends on DC-mediated T cell activation, we have crossed our DC ACT mice with Rag1-deficient mice lacking functional T cells. In CCR7-deficient (KO) mice and controls, we will further examine DOCA-salt or Ang II-induced blood pressure elevation, renal sodium retention, and dendritic cell-mediated activation of T lymphocytes in the kidney's draining lymph node. To determine whether CCR7 expression on the T cell, the DC, or both is required to mount a full hypertensive response, we will induce hypertension in CCR7 KO recipients of wild-type (WT) or CCR7 KO bone marrow, T cells, or DCs. Elucidating the mechanisms through which dendritic cells regulate T cell-dependent blood pressure elevation should aid the design of potent, immune-directed therapies for the prevention and treatment of hypertension.
Hypertension impacts 30% of adults in the United States and leads to severe cardiovascular complications including stroke, congestive heart failure, and end-stage kidney disease. The current proposal will elucidate the mechanisms through which dendritic cells activate T cells in hypertension, link T cell activation to renal sodium retention, and identify those T cells whose activation is specifically triggered by the antigens that redefine hypertension as an autoimmune disease. Knowledge of these mechanisms will allow the design of potent immune-directed therapies to more effectively lower blood pressure and limit target organ damage in hypertension.
| Wen, Yi; Crowley, Steven D (2018) Renal effects of cytokines in hypertension. Curr Opin Nephrol Hypertens 27:70-76 |
| Rucker, A Justin; Rudemiller, Nathan P; Crowley, Steven D (2018) Salt, Hypertension, and Immunity. Annu Rev Physiol 80:283-307 |
| Justin Rucker, A; Crowley, Steven D (2017) The role of macrophages in hypertension and its complications. Pflugers Arch 469:419-430 |
| Rudemiller, Nathan P; Crowley, Steven D (2017) The role of chemokines in hypertension and consequent target organ damage. Pharmacol Res 119:404-411 |
| Rudemiller, Nathan P; Crowley, Steven D (2016) Interactions Between the Immune and the Renin-Angiotensin Systems in Hypertension. Hypertension 68:289-96 |
| Madan, Babita; Patel, Mehul B; Zhang, Jiandong et al. (2016) Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis. Kidney Int 89:1062-1074 |
| Zhang, Jiandong; Rudemiller, Nathan P; Patel, Mehul B et al. (2016) Interleukin-1 Receptor Activation Potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 Co-transporter in the Nephron. Cell Metab 23:360-8 |
| Crowley, Steven D; Jeffs, Alexander D (2016) Targeting cytokine signaling in salt-sensitive hypertension. Am J Physiol Renal Physiol 311:F1153-F1158 |
| Rudemiller, Nathan P; Patel, Mehul B; Zhang, Jian-Dong et al. (2016) C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration. Am J Pathol 186:2846-2856 |
| Zhang, Jiandong; Rudemiller, Nathan P; Patel, Mehul B et al. (2016) Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI. J Am Soc Nephrol 27:2257-64 |
